EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia

Leuk Lymphoma. 2017 Jul;58(7):1753-1756. doi: 10.1080/10428194.2016.1256482. Epub 2016 Nov 16.

Authors

Mohammad O Hussaini¹, Alman Rehman², Julio C Chavez³, Javier Pinilla-Ibarz³, Pedro Horna⁴

Affiliations

¹ a Department of Hematopathology and Laboratory Medicine , H. Lee Moffitt Cancer Center , Tampa , FL , USA.
² b University of Central Florida , Orlando , FL , USA.
³ c Department of Malignant Hematology , H. Lee Moffitt Cancer Center , Tampa , FL , USA.
⁴ d Division of Hematopathology , Mayo Clinic , Rochester , MN , USA.

PMID: 27852142
DOI: 10.1080/10428194.2016.1256482

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenine / analogs & derivatives
Antineoplastic Agents / therapeutic use
Bone Marrow / pathology
Burkitt Lymphoma / diagnosis*
Diagnosis, Differential
Disease Progression
Epstein-Barr Virus Infections / complications*
Epstein-Barr Virus Infections / virology
Herpesvirus 4, Human*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
Lymphoma, Large B-Cell, Diffuse / diagnosis*
Lymphoma, Large B-Cell, Diffuse / etiology*
Male
Middle Aged
Oncogene Proteins, Fusion / genetics
Piperidines
Protein Kinase Inhibitors / therapeutic use
Pyrazoles / therapeutic use
Pyrimidines / therapeutic use

Substances

Antineoplastic Agents
Oncogene Proteins, Fusion
Piperidines
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
ibrutinib
Adenine